← back to search

Michel Boutin

Université Laval · CA
Area of research
Physiology · Rheumatology
Research interest
Research interests include Fabry disease, Chemistry, Multiplex, Tandem mass spectrometry, Mass spectrometry, and Gene isoform.
h-index
citations
252
works
4
NIH funding
primary concept
email

Recent publications

The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein
Neurobiology of Disease 2017cited by 53position: middledoi
Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34 + Cells for Correction of Fabry Disease
Molecular Therapy — Methods & Clinical Development 2017cited by 46position: middledoi
Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease
Analytical Chemistry 2016cited by 83position: firstdoi
Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry
Clinica Chimica Acta 2014cited by 70position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2016–2017)John J. Shacka · University of Alabama at Birmingham2 papers (2016–2017)Michael L. West · Dalhousie University2 papers (2014–2017)Dwayne L. Barber · National Institute of Allergy and Infectious Diseases1 papers (2017–2017) · 1 papers (2017–2017)David G. Warnock · University of Alabama at Birmingham1 papers (2014–2014)Tonia E. Tse · University of Alabama at Birmingham1 papers (2017–2017)Uma Ramaswami · Ludwig-Maximilians-Universität München1 papers (2014–2014)Jeffrey A. Medin · Medical College of Wisconsin1 papers (2017–2017)Xiaosen Ouyang · University of Alabama at Birmingham1 papers (2017–2017)Ju Huang · Hospital for Sick Children1 papers (2017–2017) · 1 papers (2017–2017)Sarah Dyack · Hospital for Sick Children1 papers (2014–2014) · 1 papers (2014–2014)Hailin Lu · University of Alabama at Birmingham1 papers (2017–2017)Armand Keating · University of Vermont1 papers (2017–2017) · 1 papers (2017–2017)Michael Nelson · University of Alabama at Birmingham1 papers (2017–2017)Axel Schambach · Medizinische Hochschule Hannover1 papers (2017–2017) · 1 papers (2017–2017)